Open Access

Comprehensive characterization of driver genes in diffuse large B cell lymphoma

  • Authors:
    • Zheng Fan
    • Renzhi Pei
    • Keya Sha
    • Lieguang Chen
    • Tiantian Wang
    • Ying Lu
  • View Affiliations

  • Published online on: April 21, 2020     https://doi.org/10.3892/ol.2020.11552
  • Pages: 382-390
  • Copyright: © Fan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Diffuse large B cell lymphoma (DLBCL) is the most common hematological malignancy and is one of the most frequent non‑Hodgkin lymphomas. Large‑scale genomic studies have defined genetic drivers of DLBCL and their association with functional and clinical outcomes. However, the lymphomagenesis of DLBCL is yet to be fully understood. In the present study, four computational tools OncodriveFM, OncodriveCLUST, integrated Cancer Genome Score and Driver Genes and Pathways were used to detect driver genes and driver pathways involved in DLBCL. The aforementioned tools were also used to perform an integrative investigation of driver genes, including co‑expression network, protein‑protein interaction, copy number variation and survival analyses. The present study identified 208 driver genes and 31 driver pathways in DLBCL. IGLL5, MLL2, BTG2, B2M, PIM1, CARD11 were the top five frequently mutated genes in DLBCL. NOTCH3, LAMC1, COL4A1, PDGFRB and KDR were the 5 hub genes in the blue module that were associated with patient age. TP53, MYC, EGFR, PTEN, IL6, STAT3, MAPK8, TNF and CDH1 were at the core of the protein‑protein interaction network. PRDM1, CDKN2A, CDKN2B, TNFAIP3, RSPO3 were the top five frequently deleted driver genes in DLBCL, while ACTB, BTG2, PLET1, CARD11, DIXDC1 were the top five frequently amplified driver genes in DLBCL. High EIF3B, MLH1, PPP1CA and RECQL4 expression was associated with decreased overall survival rate of patients with DLBCL. High XPO1 and LYN expression were associated with increased overall survival rate of patients with DLBCL. The present study improves the understanding of the biological processes and pathways involved in lymphomagenesis. The driver genes, EIF3B, MLH1, PPP1CA, RECQL4, XPO1 and LYN, pave the way for developing prognostic biomarkers and new therapeutic strategies for DLBCL.

Related Articles

Journal Cover

July 2020
Volume 20 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Fan, Z., Pei, R., Sha, K., Chen, L., Wang, T., & Lu, Y. (2020). Comprehensive characterization of driver genes in diffuse large B cell lymphoma. Oncology Letters, 20, 382-390. https://doi.org/10.3892/ol.2020.11552
MLA
Fan, Z., Pei, R., Sha, K., Chen, L., Wang, T., Lu, Y."Comprehensive characterization of driver genes in diffuse large B cell lymphoma". Oncology Letters 20.1 (2020): 382-390.
Chicago
Fan, Z., Pei, R., Sha, K., Chen, L., Wang, T., Lu, Y."Comprehensive characterization of driver genes in diffuse large B cell lymphoma". Oncology Letters 20, no. 1 (2020): 382-390. https://doi.org/10.3892/ol.2020.11552